R&D The UK can’t just be a life sciences lab – we need manufactu... Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.
R&D From promise to reality: Unlocking the true business potenti... The genomic medicine space has seen incredible success, but investors are overlooking it.
Patients How prioritising sustainability efforts yields long-term gro... The pharmaceutical industry is at a pivotal juncture.
Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
R&D Dark factories for a bright future Much like medicine itself, drug manufacturing has evolved rapidly over recent decades.
News BMS says it will set Cobenfy's UK price the same as the US Bristol Myers Squibb's price tag for schizophrenia drug Cobenfy in the UK is a manifestation of Trump's most favoured nation drug pricing policy.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.
